• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用不同培养策略在大肠杆菌中乳糖诱导产生人可溶性B淋巴细胞刺激因子(hsBLyS)

Lactose-induced production of human soluble B lymphocyte stimulator (hsBLyS) in E. coli with different culture strategies.

作者信息

Li Zhaopeng, Zhang Xu, Tan Tianwei

机构信息

College of Life Science and Technology, Beijing University of Chemical Technology, 100029, Beijing, PR China.

出版信息

Biotechnol Lett. 2006 Apr;28(7):477-83. doi: 10.1007/s10529-006-0002-y.

DOI:10.1007/s10529-006-0002-y
PMID:16614929
Abstract

Over-production of human soluble B lymphocyte stimulator (hsBLyS) was carried out with four different fed-batch culture strategies using lactose as inducer, instead of IPTG, in a fed-batch culture of Escherichia coli. As lactose acted as both inducer and carbon source, the best and simplest culture strategy was direct feeding of lactose after batch culture, thereby giving hsBLyS at 3.7 g l(-1) and a productivity of 0.11 g l(-1) h(-1).

摘要

在大肠杆菌的补料分批培养中,采用四种不同的补料分批培养策略,以乳糖替代异丙基-β-D-硫代半乳糖苷(IPTG)作为诱导剂,进行人可溶性B淋巴细胞刺激因子(hsBLyS)的过量表达。由于乳糖既是诱导剂又是碳源,最佳且最简单的培养策略是在分批培养后直接补加乳糖,从而获得了3.7 g l⁻¹的hsBLyS,生产率为0.11 g l⁻¹ h⁻¹。

相似文献

1
Lactose-induced production of human soluble B lymphocyte stimulator (hsBLyS) in E. coli with different culture strategies.采用不同培养策略在大肠杆菌中乳糖诱导产生人可溶性B淋巴细胞刺激因子(hsBLyS)
Biotechnol Lett. 2006 Apr;28(7):477-83. doi: 10.1007/s10529-006-0002-y.
2
Effect of postinduction nutrient feed composition and use of lactose as inducer during production of thermostable xylanase in Escherichia coli glucose-limited fed-batch cultivations.在大肠杆菌葡萄糖限制补料分批培养中生产热稳定木聚糖酶期间,诱导后营养物进料组成及使用乳糖作为诱导剂的影响。
J Biosci Bioeng. 2005 May;99(5):477-84. doi: 10.1263/jbb.99.477.
3
Batch and fed-batch cultivation for excretive production of human epidermal growth factor (hEGF) with recombinant E. Coli K12 system.利用重组大肠杆菌K12系统分批培养和补料分批培养以分泌生产人表皮生长因子(hEGF)
Prep Biochem Biotechnol. 2008;38(3):271-81. doi: 10.1080/10826060802165089.
4
Novel escherichia coli strain allows efficient recombinant protein production using lactose as inducer.新型大肠杆菌菌株可利用乳糖作为诱导剂高效生产重组蛋白。
Biotechnol Bioeng. 2003 Jun 30;82(7):809-17. doi: 10.1002/bit.10630.
5
Growing E. coli to high cell density--a historical perspective on method development.将大肠杆菌培养至高细胞密度——方法发展的历史视角
Biotechnol Adv. 2005 Jul;23(5):345-57. doi: 10.1016/j.biotechadv.2005.04.004.
6
[Hepatitis E virus capsid protein production by high cell density culture of recombinant Escherichia coli].[通过重组大肠杆菌的高细胞密度培养生产戊型肝炎病毒衣壳蛋白]
Sheng Wu Gong Cheng Xue Bao. 2004 May;20(3):450-5.
7
A proposed feeding strategy for the overproduction of recombinant proteins in Escherichia coli.一种用于在大肠杆菌中过量生产重组蛋白的拟议喂养策略。
Biotechnol Appl Biochem. 2008 Feb;49(Pt 2):141-7. doi: 10.1042/BA20070089.
8
Production of biomass and recombinant human-like collagen in Escherichia coli processes with different CO2 pulses.在具有不同二氧化碳脉冲的大肠杆菌培养过程中生物质和重组类人胶原蛋白的产生。
Biotechnol Lett. 2009 Feb;31(2):221-6. doi: 10.1007/s10529-008-9852-9. Epub 2008 Oct 16.
9
Fed-batch culture of a metabolically engineered Escherichia coli strain designed for high-level succinate production and yield under aerobic conditions.在需氧条件下,对一种经过代谢工程改造的大肠杆菌菌株进行补料分批培养,该菌株旨在实现高水平琥珀酸的生产和产量。
Biotechnol Bioeng. 2005 Jun 20;90(6):775-9. doi: 10.1002/bit.20458.
10
High-level expression of a fungal pyranose oxidase in high cell-density fed-batch cultivations of Escherichia coli using lactose as inducer.使用乳糖作为诱导剂,在大肠杆菌的高细胞密度补料分批培养中实现真菌吡喃糖氧化酶的高水平表达。
Protein Expr Purif. 2004 Jul;36(1):61-9. doi: 10.1016/j.pep.2004.02.011.

引用本文的文献

1
ClearColi as a platform for untagged pneumococcal surface protein A production: cultivation strategy, bioreactor culture, and purification.ClearColi 作为无标签肺炎链球菌表面蛋白 A 生产的平台:培养策略、生物反应器培养和纯化。
Appl Microbiol Biotechnol. 2022 Feb;106(3):1011-1029. doi: 10.1007/s00253-022-11758-9. Epub 2022 Jan 13.
2
Expression of the human molecular chaperone domain Bri2 BRICHOS on a gram per liter scale with an E. coli fed-batch culture.以大肠杆菌分批补料培养方式实现每升克级表达人类分子伴侣域 Bri2 BRICHOS。
Microb Cell Fact. 2021 Jul 30;20(1):150. doi: 10.1186/s12934-021-01638-8.
3
Scale-up fermentation of Escherichia coli for the production of recombinant endoglucanase from Clostridium thermocellum.
从梭菌属嗜热纤维梭菌生产重组内切葡聚糖酶的大肠杆菌发酵放大。
Sci Rep. 2021 Mar 30;11(1):7145. doi: 10.1038/s41598-021-86000-z.
4
Cost analysis based on bioreactor cultivation conditions: Production of a soluble recombinant protein using BL21(DE3).基于生物反应器培养条件的成本分析:使用BL21(DE3)生产可溶性重组蛋白。
Biotechnol Rep (Amst). 2020 Feb 22;26:e00441. doi: 10.1016/j.btre.2020.e00441. eCollection 2020 Jun.
5
Biochemical properties and yields of diverse bacterial laccase-like multicopper oxidases expressed in Escherichia coli.在大肠杆菌中表达的多种细菌漆酶样多铜氧化酶的生化特性及产量
Sci Rep. 2015 Jun 12;5:10465. doi: 10.1038/srep10465.
6
Non-conventional induction strategies for production of subunit swine erysipelas vaccine antigen in rE. coli fed-batch cultures.在重组大肠杆菌补料分批培养中生产亚单位猪丹毒疫苗抗原的非常规诱导策略。
Springerplus. 2013 Jul 17;2:322. doi: 10.1186/2193-1801-2-322. eCollection 2013.
7
Production of glycoprotein vaccines in Escherichia coli.在大肠杆菌中生产糖蛋白疫苗。
Microb Cell Fact. 2010 Aug 11;9:61. doi: 10.1186/1475-2859-9-61.